{
    "resourceType": "ValueSet",
    "id": "2.16.840.1.113762.1.4.1287.7",
    "meta": {
        "versionId": "5",
        "lastUpdated": "2025-02-19T03:17:25.000-05:00",
        "profile": [
            "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
            "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
            "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
        ]
    },
    "extension": [
        {
            "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
            "valueContactDetail": {
                "name": "Industrial Technology Research Institute Author"
            }
        },
        {
            "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
            "valueDate": "2024-12-23"
        },
        {
            "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
            "valueDate": "2024-11-27"
        }
    ],
    "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1287.7",
    "identifier": [
        {
            "system": "urn:ietf:rfc:3986",
            "value": "urn:oid:2.16.840.1.113762.1.4.1287.7"
        }
    ],
    "version": "20241127",
    "name": "Iodine131CancerFollowUpExaminationWithThyrogenInjection",
    "title": "Iodine 131 Cancer Follow Up Examination with Thyrogen Injection",
    "status": "active",
    "date": "2024-12-26T08:38:32-05:00",
    "publisher": "Industrial Technology Research Institute Steward",
    "description": "26074C",
    "jurisdiction": [
        {
            "extension": [
                {
                    "url": "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
                    "valueCode": "unknown"
                }
            ]
        }
    ],
    "purpose": "(Clinical Focus: The purpose of this value set is to represent clinical concepts related to Iodine 131 Cancer Follow Up Examination with Thyrogen Injection.),(Data Element Scope: The value set includes codes and descriptors that capture the procedural techniques, therapeutic agents, and clinical indications for monitoring cancer recurrence or residual disease.),(Inclusion Criteria: Patients with recurrent or metastatic thyroid cancer),(Exclusion Criteria: Preparation for examination or treatment of thyroid cancer patients who are not suitable for stopping T4)",
    "compose": {
        "include": [
            {
                "system": "http://hl7.org/fhir/sid/icd-10-cm",
                "concept": [
                    {
                        "code": "C73",
                        "display": "Malignant neoplasm of thyroid gland"
                    },
                    {
                        "code": "C79.89",
                        "display": "Secondary malignant neoplasm of other specified sites"
                    }
                ]
            }
        ]
    }
}